Viola Macolić Šarinić

Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?

Linda Härmark, June Raine, Hubert G. M. Leufkens et al. · Drug Safety · 2016 · 72 citations

Drug Safety, Health Policy, Patient Safety +6

Adverse drug reactions caused by drug-drug interactions reported to Croatian Agency for Medicinal Products and Medical Devices: a retrospective observational study

Nikica Mirošević Skvrce, Viola Macolić Šarinić, Iva Mucalo et al. · Croatian Medical Journal · 2011 · 58 citations · Full text

<i>ABCG2</i> Gene Polymorphisms as Risk Factors for Atorvastatin Adverse Reactions: A Case–Control Study

Nikica Mirošević Skvrce, Viola Macolić Šarinić, Iveta Šimić et al. · Pharmacogenomics · 2015 · 36 citations

<i>CYP2C9</i> and <i>ABCG2</i> Polymorphisms as Risk Factors for Developing Adverse Drug Reactions in Renal Transplant Patients Taking Fluvastatin: A Case–Control Study

Nikica Mirošević Skvrce, Nada Božina, Lada Zibar et al. · Pharmacogenomics · 2013 · 31 citations

Clinical Application of Genotype-guided Dosing of Warfarin in Patients with Acute Stroke

Svjetlana Šupe, Zdravka Poljaković, Tamara Božina et al. · Archives of Medical Research · 2015 · 18 citations

Thrombosis, Cardiovascular Disease, Medicine +14